Selective Defunctioning Stoma in Low Anterior Resection for Rectal Cancer
- Disease/Condition
- Rectal Cancer
- Drug/Device/Intervention
- selective approach defunctioning stoma
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Skane University Hospital
- Phase
- N/A
- Start date
- Sep 01, 2024
- End date
- Dec 31, 2030
- Enrollment
- 212 participants
textbook outcome; stoma-free survival at two years without major LARS
The goal of this observational trial with a nested randomized controlled trial is to
 investigate a selective approach of defunctioning stoma in low anterior resection in rectal
 cancer patients. The primary outcome is a hybrid so-called textbook outcome; stoma-free
 survival at two years without major LARS, reflecting a functionally appropriate outcome after
 low anterior resection for rectal cancer. Secondary outcomes include anastomotic leakage,
 postoperative mortality, reinterventions, stoma-related complications, quality of life
 measures, LARS, and permanent stoma rate up to two years after index surgery.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06214988
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06214988 through Pure Global AI's free database. This phase not specified trial is sponsored by Skane University Hospital and is currently Not yet recruiting. The study focuses on Rectal Cancer. Target enrollment is 212 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.